MIAT can act as an endogenous competing RNA to negatively regulate microRNA-874-3p to reduce the level of pro-inflammatory factor IL-1β and reduce the neuroinflammatory response induced by cerebral ischemia/reperfusion (39). The gene discussed is IL1B; the disease is brain ischemia.